Sionna Therapeutics (NASDAQ:SION) Shares Gap Down – What’s Next?

Sionna Therapeutics, Inc. (NASDAQ:SION)’s stock price gapped down prior to trading on Monday . The stock had previously closed at $12.14, but opened at $11.85. Sionna Therapeutics shares last traded at $12.31, with a volume of 562 shares changing hands.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the company. Guggenheim assumed coverage on Sionna Therapeutics in a research report on Tuesday, March 4th. They issued a “buy” rating and a $45.00 price target on the stock. Stifel Nicolaus assumed coverage on Sionna Therapeutics in a research report on Tuesday, March 4th. They issued a “buy” rating and a $32.00 price target on the stock. Finally, TD Cowen started coverage on Sionna Therapeutics in a research report on Tuesday, March 4th. They issued a “buy” rating on the stock.

Sionna Therapeutics Stock Performance

The company’s 50 day simple moving average is $12.81.

Sionna Therapeutics (NASDAQ:SION) last released its quarterly earnings results on Thursday, March 20th. The company reported ($3.38) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($2.68) by ($0.70).

About Sionna Therapeutics

We are a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (“CF”) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (“CFTR”) protein to deliver clinically meaningful benefit to CF patients.